Iterum Therapeutics PLC ITRM
$0.03 $0.04 (57.39%) 1D
Last Updated: Mar 31, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
ITRM Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Iterum Therapeutics PLC is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Iterum Therapeutics PLC. Stock Analysis ITRM
United States Health Care Nano Cap Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company is headquartered in Dublin, Dublin and currently employs 9 full-time employees. The company went IPO on 2018-05-25. The firm develops differentiated anti-infectives. The company offers ORLYNVAH (sulopenem in an oral tablet formulation) medicine, which is an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. The firm operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Iterum Therapeutics PLC (ITRM) Chart
Financial Metrics & Statements of Iterum Therapeutics PLC (ITRM)
FAQ's for Iterum Therapeutics PLC (ITRM)
- As of August 2026, Iterum Therapeutics PLC ITRM is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Iterum Therapeutics PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Iterum Therapeutics PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Iterum Therapeutics PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Iterum Therapeutics PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Iterum Therapeutics PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Iterum Therapeutics PLC (ITRM)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
